LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

Stock Information for LifeMD Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About LifeMD Inc.

Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm
LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD Recognized by the 2025 Deloitte Technology Fast 500(TM) and by TIME's America's Growth Leaders of 2026
LifeMD Reports Third Quarter 2025 Results
LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk
LifeMD to Participate in the BTIG Digital Health Forum
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.